EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Understanding the clinical and environmental drivers of antifungal resistance in the One Health context

Catrin C Williams, Jack B Gregory, Jane Usher

Microbiology · 30.10.2024 · 170 (10)

DOI: 10.1099/mic.0.001512 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microbiology, erschienen am 30.10.2024. Verfasst von Catrin C Williams und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Council Centre for Medical Mycology, University of Exeter, Exeter, UK. Hauptthemen laut MEDLINE: Antifungal Agents, Drug Resistance, Fungal, Aspergillus fumigatus, One Health. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 202 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antifungal drugs have had a tremendous impact on human health and the yields of crops. However, in recent years, due to usage both in a health setting and in agriculture, there has been a rapid emergence of antifungal drug resistance that has outpaced novel compound discovery. It is now globally recognized that new strategies to tackle fungal infection are urgently needed, with such approaches requiring the cooperation of both sectors and the development of robust antifungal stewardship rationales. In this review, we examine the current antifungal regimes in clinical and agricultural settings, focusing on two pathogens of importance, Candida auris and Aspergillus fumigatus, examining their drivers of antifungal resistance, the impact of dual-use azoles and the impact agricultural practices have on driving the emergence of resistance. Finally, we postulate that a One Health approach could offer a viable alternative to prolonging the efficacy of current antifungal agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsDrug Resistance, FungalAspergillus fumigatusOne HealthHumansCandida aurisAspergillosisAzolesAgricultureCandidiasis

Stichwörter der Autor:innen

AFRAMRAspergillusCandidaOne Healthazolesresistance

Substanzen

Antifungal AgentsAzoles

Autor:innen und Institutionen

  • Medical Research Council Centre for Medical Mycology, University of Exeter, Exeter, UK.

Förderung

  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Williams, C. C., Gregory, J. B., & Usher, J. (2024). Understanding the clinical and environmental drivers of antifungal resistance in the One Health context. Microbiology, 170(10). https://doi.org/10.1099/mic.0.001512

Vancouver

Williams CC, Gregory JB, Usher J. Understanding the clinical and environmental drivers of antifungal resistance in the One Health context. Microbiology. 2024;170(10). doi:10.1099/mic.0.001512

BibTeX
@article{Williams2024,
  author = {Williams, Catrin C and Gregory, Jack B and Usher, Jane},
  title = {Understanding the clinical and environmental drivers of antifungal resistance in the One Health context},
  journal = {Microbiology},
  year = {2024},
  volume = {170},
  number = {10},
  doi = {10.1099/mic.0.001512}
}
Kostenlos starten →